Role of sodium glucose cotransporter type 2 inhibitors dapagliflozin on diabetic nephropathy in rats; Inflammation, angiogenesis and apoptosis

This publication has 64 references indexed in Scilit:

• Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
  The Journal of Clinical Endocrinology & Metabolism, 2012
• The interstitial expression of alpha-smooth muscle actin in glomerulonephritis is associated with renal function
  Medical Science Monitor, 2012
• Renal function in diabetic nephropathy
  World Journal of Diabetes, 2010
• Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients
  Diabetes Research and Clinical Practice, 2008
• Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats
  Diabetes, 2008
• Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy
  American Journal of Physiology-Renal Physiology, 2008
• The Role of Inflammatory Cytokines in Diabetic Nephropathy
  Journal of the American Society of Nephrology, 2008
• Plasma Pentraxin 3 in Patients with Chronic Kidney Disease
  Clinical Journal of the American Society of Nephrology, 2007
• The role of TNF-α in diabetic nephropathy: Pathogenic and therapeutic implications
  Cytokine & Growth Factor Reviews, 2006
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2^−ΔΔC_T Method
  Methods, 2001